Pharmexcil urges a review of a new rule for drug exports in India, which requires a product registration certificate from the ...

DCGI has sought post-market surveillance data from the drugmakers of two fixed-dose combination medicines—Imipramine Hydrochloride IP + Diazepam IP tablets used to ease co-morbid anxiety, and ...

In a communication, the DCGI has asked the drug control authorities ... Going forward, the CDSCO is updating the export NOC checklist to ensure that either the product registration certificate ...

The move came following reports that unapproved combinations of these drugs, exported to West African countries, are contributing to an opioid crisis in the region.

The Drugs Controller General of India (DCGI) has prohibited the production and export of all combinations of pain-relief medicines tapentadol and carisoprodol over news reports that unapproved ...

Raghuvanshi is set to superannuate on February 28. Raghuvanshi was appointed as the DCGI, head of the Central Drugs Standard Control Organisation (CDSCO), the Indian drug regulatory body on ...

At the 63rd Annual Day Celebrations of the Indian Drug Manufacturers Association (IDMA) in Mumbai recently, Dr Rajeev Raghuvanshi, Drugs Controller General of India (DCGI), delivered a compelling ...

Recognising the critical role of pharmacists in the evolving healthcare ecosystem, the Academy of Digital Health Sciences, in collaboration with Bombay College of Pharmacy and the Indian Institute of ...